These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11824091)

  • 1. A new era for the Pap test.
    Holladay EB; Allen KA
    JAAPA; 2001 Dec; 14(12):53-6. PubMed ID: 11824091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Errors in pathology and laboratory medicine: consequences and prevention.
    Hollensead SC; Lockwood WB; Elin RJ
    J Surg Oncol; 2004 Dec; 88(3):161-81. PubMed ID: 15562462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?
    Howard K; Salkeld G; McCaffery K; Irwig L
    Health Econ; 2008 May; 17(5):593-605. PubMed ID: 17764095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice.
    Santillan A; Govan L; Zahurak ML; Diaz-Montes TP; Giuntoli RL; Bristow RE
    Gynecol Oncol; 2008 Jun; 109(3):388-93. PubMed ID: 18405946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cytology specimen adequacy: patient management guidelines and optimizing specimen collection.
    Davey DD; Cox JT; Austin RM; Birdsong G; Colgan TJ; Howell LP; Husain M; Darragh TM
    J Low Genit Tract Dis; 2008 Apr; 12(2):71-81. PubMed ID: 18369299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators.
    Davey DD; Austin RM; Birdsong G; Buck HW; Cox JT; Darragh TM; Elgert PA; Hanson V; Henry MR; Waldman J;
    Am J Clin Pathol; 2002 Nov; 118(5):714-8. PubMed ID: 12428791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS).
    Eltoum IA; Roberson J
    Cancer; 2007 Feb; 111(1):34-40. PubMed ID: 17262799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-effectiveness analysis of four management strategies in the determination and follow-up of atypical squamous cells of undetermined significance.
    Hughes AA; Glazner J; Barton P; Shlay JC
    Diagn Cytopathol; 2005 Feb; 32(2):125-32. PubMed ID: 15637677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and outcome of cervical cancer prevention failures in the United States.
    Raab SS; Grzybicki DM; Zarbo RJ; Jensen C; Geyer SJ; Janosky JE; Meier FA; Vrbin CM; Carter G; Geisinger KR
    Am J Clin Pathol; 2007 Nov; 128(5):817-24. PubMed ID: 17951205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of specimen order on Chlamydia trachomatis and Neisseria gonorrhoeae test performance and adequacy of Papanicolaou smear.
    Ghanem KG; Koumans EH; Johnson RE; Sawyer MK; Papp JR; Unger ER; Black CM; Markowitz LE
    J Pediatr Adolesc Gynecol; 2006 Feb; 19(1):23-30. PubMed ID: 16472725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMOs should stress quality tests in light of pap smear controversy.
    Johnson DE
    Contract Healthc; 1988 Feb; ():27. PubMed ID: 10318142
    [No Abstract]   [Full Text] [Related]  

  • 12. Accuracy of reporting endocervical component adequacy--a continuous quality improvement project.
    Roberson J; Connolly K; St John K; Eltoum I; Chhieng DC
    Diagn Cytopathol; 2002 Sep; 27(3):181-4. PubMed ID: 12203868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of the cytology laboratory: specimen processing through diagnosis.
    Joste N
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):549-63; viii. PubMed ID: 19061816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological, behavioral, and interpersonal impact of human papillomavirus and Pap test results.
    Kahn JA; Slap GB; Bernstein DI; Kollar LM; Tissot AM; Hillard PA; Rosenthal SL
    J Womens Health (Larchmt); 2005 Sep; 14(7):650-9. PubMed ID: 16181021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing in cervicovaginal cytology.
    Koss LG
    Arch Pathol Lab Med; 2006 Jan; 130(1):13. PubMed ID: 16390229
    [No Abstract]   [Full Text] [Related]  

  • 16. Pap smear knowledge among young women following the introduction of the HPV vaccine.
    Head SK; Crosby RA; Moore GR
    J Pediatr Adolesc Gynecol; 2009 Aug; 22(4):251-6. PubMed ID: 19646672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labeling liquid-based systems: FDA clarification.
    Gutman S
    J Reprod Med; 2000 Nov; 45(11):969-70. PubMed ID: 11127121
    [No Abstract]   [Full Text] [Related]  

  • 18. [Papanicolau smears: reducing the false negative rate by improving the method].
    Biran G; Levy T
    Harefuah; 2004 Mar; 143(3):217-21, 245. PubMed ID: 15065363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid-based cytology for cervical cancer screening.
    Bentz JS
    Expert Rev Mol Diagn; 2005 Nov; 5(6):857-71. PubMed ID: 16255628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choice.
    McCaffery KJ; Irwig L; Chan SF; Macaskill P; Barratt A; Lewicka M; Clarke J; Weisberg E
    Patient Educ Couns; 2008 Dec; 73(3):473-9, 481. PubMed ID: 18757164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.